Novo Nordisk Foundation funds GPAP
The Novo Nordisk Foundation is funding the Global Pathogen Analysis Platform (GPAP) with up to DKK 200 million over six years, to strengthen global defenses against future pandemics.
Read the Novo Nordisk Foundation’s announcement. For official GPAP news, see gpap.global/news.
Samir Bhatt
Professor, FMedSci, MAE; Scientific Director of GPAP
Statistics, machine learning and Bayesian inference for public health and infectious diseases.